These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20389174)

  • 21. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.
    de Bortoli N; Martinucci I; Savarino E; Franchi R; Bertani L; Russo S; Ceccarelli L; Costa F; Bellini M; Blandizzi C; Savarino V; Marchi S
    Dis Esophagus; 2016 Jan; 29(1):3-9. PubMed ID: 25212408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exacerbation of gastroesophageal reflux symptoms after discontinuation of proton pump inhibitors is not associated with increased esophageal acid exposure.
    Hoshikawa Y; Nikaki K; Sonmez S; Nakagawa K; Yazaki E; Sifrim D; Woodland P
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13735. PubMed ID: 31657519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.
    Triadafilopoulos G; Zikos T; Regalia K; Sonu I; Fernandez-Becker NQ; Nguyen L; Nandwani MCR; Clarke JO
    Dig Dis Sci; 2018 Oct; 63(10):2673-2680. PubMed ID: 29959725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.
    Tong S; Mallitt KA; Krishnan U
    Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.
    Viazis N; Katopodi K; Karamanolis G; Denaxas K; Varytimiadis L; Galanopoulos M; Tsoukali E; Kamberoglou D; Christidou A; Karamanolis DG; Papatheodoridis G; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1054-1058. PubMed ID: 28628496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
    Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chest pain and gastroesophageal reflux disease.
    Richter JE
    J Clin Gastroenterol; 2000 Apr; 30(3 Suppl):S39-41. PubMed ID: 10777171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Review of Diagnosis of GERD.
    Jeong ID
    Korean J Gastroenterol; 2017 Feb; 69(2):96-101. PubMed ID: 28239077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Noncardiac chest pain and gastroesophageal reflux disease].
    Dimache M; Turcan E; Nătase M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
    Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
    Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of gastroesophageal reflux disease in chest pain.
    Pellicano R; Durazzo M; Oliaro E; Fagoonee S; Oliaro A; Rizzetto M
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):553-7. PubMed ID: 12124573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noncardiac chest pain.
    Katz PO
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S32-9. PubMed ID: 17710075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors predictive of gastroesophageal reflux disease and esophageal motility disorders in patients with non-cardiac chest pain.
    Gomez Cifuentes J; Lopez R; Thota PN
    Scand J Gastroenterol; 2018 Jun; 53(6):643-649. PubMed ID: 29848163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on noncardiac chest pain.
    Shrestha S; Pasricha PJ
    Dig Dis; 2000; 18(3):138-46. PubMed ID: 11279332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of heartburn not responding to proton pump inhibitors.
    Fass R; Sifrim D
    Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
    Kahrilas PJ; Hughes N; Howden CW
    Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis management of gastroesophageal reflux disease in adults].
    Abbes L; Zinzindohoué F
    Rev Prat; 2016 Dec; 66(10):1086-1089. PubMed ID: 30512472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current Status of Translational Research on Gastroesophageal Reflux Disease].
    Jeong ID; Park MI
    Korean J Gastroenterol; 2016 Sep; 68(3):127-31. PubMed ID: 27646580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.